1. Home
  2. UHT vs CTMX Comparison

UHT vs CTMX Comparison

Compare UHT & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UHT
  • CTMX
  • Stock Information
  • Founded
  • UHT 1986
  • CTMX 2008
  • Country
  • UHT United States
  • CTMX United States
  • Employees
  • UHT 5
  • CTMX N/A
  • Industry
  • UHT Real Estate Investment Trusts
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • UHT Real Estate
  • CTMX Health Care
  • Exchange
  • UHT Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • UHT 515.7M
  • CTMX 544.2M
  • IPO Year
  • UHT N/A
  • CTMX 2015
  • Fundamental
  • Price
  • UHT $37.17
  • CTMX $3.32
  • Analyst Decision
  • UHT
  • CTMX Strong Buy
  • Analyst Count
  • UHT 0
  • CTMX 5
  • Target Price
  • UHT N/A
  • CTMX $5.30
  • AVG Volume (30 Days)
  • UHT 79.6K
  • CTMX 4.3M
  • Earning Date
  • UHT 10-23-2025
  • CTMX 11-06-2025
  • Dividend Yield
  • UHT 7.95%
  • CTMX N/A
  • EPS Growth
  • UHT N/A
  • CTMX 263.20
  • EPS
  • UHT 1.30
  • CTMX 0.49
  • Revenue
  • UHT $99,952,000.00
  • CTMX $141,100,000.00
  • Revenue This Year
  • UHT N/A
  • CTMX N/A
  • Revenue Next Year
  • UHT $0.81
  • CTMX N/A
  • P/E Ratio
  • UHT $28.63
  • CTMX $6.80
  • Revenue Growth
  • UHT 0.31
  • CTMX 18.01
  • 52 Week Low
  • UHT $34.56
  • CTMX $0.40
  • 52 Week High
  • UHT $43.52
  • CTMX $3.49
  • Technical
  • Relative Strength Index (RSI)
  • UHT 32.82
  • CTMX 75.86
  • Support Level
  • UHT $38.60
  • CTMX $3.11
  • Resistance Level
  • UHT $39.36
  • CTMX $3.39
  • Average True Range (ATR)
  • UHT 0.96
  • CTMX 0.24
  • MACD
  • UHT -0.47
  • CTMX 0.10
  • Stochastic Oscillator
  • UHT 7.96
  • CTMX 90.91

About UHT Universal Health Realty Income Trust

Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: